Irwin Naturals Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Klee Irwin
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 5310 Beethoven Street Los Angeles CA United States of America 90066
- IPO Date
- Oct 21, 2021
- Website
- irwinnaturals.com
- Similar Companies
- Business
- Irwin Naturals Inc., a brand recognized for its health and wellness offerings, has cultivated a portfolio spanning nutritional supplements and plant-based solutions. The company develops and distributes a variety of vitamins, specialized herbal blends, and hemp-derived CBD products across North America and beyond. These items are available through various retail channels, including major mass market stores and health food outlets, alongside a growing online presence. Historically, Irwin Naturals expanded its reach into mental health by establishing a network of ketamine treatment clinics under the "Irwin Naturals Emergence" banner, and also licensed its name for THC-infused cannabis products. Following a Chapter 11 reorganization filing in August 2024, the company's assets were acquired by FitLife Brands in August 2025, with the intent to leverage Irwin's established brand and expand its digital sales capabilities. The enterprise maintains its base in Los Angeles, California.
Irwin Naturals Reports Q3 2023 Financial Results
Irwin Naturals Reports Q2 2023 Financial Results
Irwin Naturals launches cannabis tincture products in California
Irwin Naturals Unleashes Trio of Cannabis Tinctures in Golden State
Irwin Naturals says it made progress in the high-growth cannabis and psychedelics markets in 1Q
Irwin Naturals highlights expansion into cannabis and psychedelics sectors as it posts 2022 results
Irwin Naturals launches cannabis products nationwide in Canada
Irwin Naturals closes acquisition of Ketamine Media owner
Braxia Scientific announces termination of Irwin Naturals merger LOI; retains strategic clinical assets
Braxia Scientific reports 50.5% increase in 3Q revenue; updates on acquisition by Irwin Naturals
Irwin Naturals says it has successfully completed the acquisition of Serenity Health
Irwin Naturals secures $40M credit facility to support expansion of psychedelic mental health clinics
Irwin Naturals announces LOI to acquire Braxia Scientific to create new market leader
Irwin Naturals inks licensing deal to distribute Irwin Naturals cannabis products in Oklahoma
Irwin Naturals an Braxia Scientific partner to accelerate in-human development of new therapies for mental health
Irwin Naturals inks licensing deal to distribute its THC products in Oregon
Irwin Naturals completes acquisition of three mental-healthcare clinics in Florida
Irwin Naturals makes progress with its expansion strategy in 3Q
Irwin Naturals inks deal to acquire Kentucky-based Serenity Health
Irwin Naturals expands network of psychedelic mental healthcare clinics with acquisition of Washington ketamine facility